We are thrilled to announce that ArtiQ has been acquired by Clario, a leading healthcare research and technology company renowned for its groundbreaking contributions to clinical evidence generation.

by Nevena Mikic Apr 2, 2024

Clario integrates AI into clinical trial data collection for spirometry with new partnership with ArtiQ 

by Yuri Van Havere Mar 1, 2023

Artificiële Intelligentie helpt huisartsen longziekten opsporen

by adm_dev Feb 8, 2023

ArtiQ ranked in the CB Insights’ 2022 ‘Digital Health 150’ List

by Yuri Van Havere Dec 13, 2022

NuvoAir Partners with ArtiQ to Provide AI-Based Over-Reading of Spirometry to Improve Efficiency of Clinical Trials

by Yuri Van Havere Oct 26, 2022

ArtiQ and patientMpower join forces to provide the best quality home spirometry to patients and healthcare professionals

by Yuri Van Havere May 11, 2022

Boehringer Ingelheim and ArtiQ join forces to help bring specialist-level expertise to all levels of care.

by Yuri Van Havere Mar 3, 2022

ArtiQ presented at the International Respiratory Summit at the EXPO 2020.

by Yuri Van Havere Nov 19, 2021

ArtiQ Wins UK Government Funding for its AI Algorithms to Support Timely Diagnosis of Lung Diseases

by Yuri Van Havere Jun 16, 2021

ArtiQ announces a partnership with Vyaire Medical to bring its ArtiQ.PFT software to hospitals across Europe.

by Yuri Van Havere Apr 8, 2021

ArtiQ obtains ISO 13485 and CE marking (MDR) certification.

by Yuri Van Havere Jan 28, 2021

ArtiQ awarded a € 450 000 grant from VLAIO

by Yuri Van Havere Nov 3, 2020

Diagnosis of Interstitial Lung Disease (ILD) - Interview with professor Wim Wuyts

by Yuri Van Havere Sep 28, 2020

Watch the presentation below to get an overview of the latest applications of AI in respiratory medicine and to learn how doctors and AI can work together as a complimentary team.

by Yuri Van Havere Sep 24, 2020

Standardization of ATS/ERS quality criteria or spirometry - interview wit Nilakash Das.

by Yuri Van Havere Aug 6, 2020

ArtiQ in Artsenkrant.

by Yuri Van Havere Apr 22, 2020

ArtiQ, a KU Leuven spin-off company which helps doctors diagnose, treat and monitor respiratory problems, announces that it has successfully concluded its seed financing round, raising € 1 million euro. The financing will be used to launch ArtiQ|PFT, a decision support tool that offers pulmonologists a fast, reliable and standardized evaluation of a patient’s lung function.

by Yuri Van Havere Jun 18, 2019